Simon KAVANAGH ; Vera BRIL ; Jeffrey H LIPTON
Blood Research 2018;53(2):172-174
No abstract available. Imatinib Mesylate* ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive* ; Peripheral Nervous System Diseases*